Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer

miR-137 downregulation was related to its promoter hypermethylation in lung cancer. Further studies are needed to assess its value as a prognostic factor and potential therapeutic applications in lung cancer.